3 Stocks at 52-Week Lows I’m Buying Right Now

These three stocks continue to trade at or near 52-week lows. But this provides perhaps the best opportunity for long-term holders.

| More on:
Target. Stand out from the crowd

Image source: Getty Images

The TSX today continues to be filled with great companies trading at 52-week lows. In fact, some of them provide incredible opportunities for investors willing to wait it out.

In the case of these three TSX stocks, that wait should mean a turnaround in the next year. Yet over the next few years, this could turn into significant gains. Let’s look at the three I would consider on the TSX today.

CIBC stock

First off, Canadian Imperial Bank of Commerce (TSX:CM) is the perfect option for risk-averse investors. While shares are down, this is because CIBC stock has a lot of exposure to the Canadian housing sector. Still, once prices recover and housing is created on a massive scale in the next year, this could prove a great point for investors.

That’s especially since CIBC stock has less exposure to the United States, where banks continue to see losses. Canadian banks have provisions for these loan losses and enjoy an oligopoly here at home. So, CIBC stock should be able to recover nicely.

In fact, shares continue to trade near 52-week lows, currently at $56 per share compared to lows at $53. I would therefore consider picking it up on the TSX today for a potential upside of 27% to reach 52-week highs as of writing. Plus, a 6.03% dividend yield to grab as well.

NorthWest REIT

Another of the stocks trading near 52-week lows on the TSX today is NorthWest Healthcare Properties REIT (TSX:NWH.UN). NorthWest stock recently saw a touch of positive movement after earnings. This came as there was stable growth from the company, and a United Kingdom joint venture coming online by June 30.

Yet NorthWest stock currently trades at $8.09 per share as of writing, with 52-week lows at $7.78. While investors may not have liked that the company was attempting to grow during high interest rates and inflation, NorthWest stock is setting itself up for long-term income.

That income remain stable with occupancy remaining at 97%, and a 13.6-year average lease agreement. So, I would certainly consider grabbing the company on the TSX today, especially with a 10.04% dividend yield.

Canopy Growth stock

Finally, Canopy Growth (TSX:WEED) is the last of the stocks trading near 52-week lows on the TSX today I would consider. It’s definitely not for the risk averse, as there is still a lot of work to do from the company.

Yet the drop in share price is far over done, with shares coming down from all-time highs at around $70, to where it sits now at $1.43 as of writing. That’s just $0.05 higher than 52-week lows, and it could certainly drop once more. Even so, a small stake could turn into a fortune — not this year, mind you, but the next decade? Potentially, yes!

Canopy Growth stock is setting itself up to be the largest producer in the country set up to be the largest consumer of cannabis. It’s made significant cuts and focuses on generating profit through non-THC products. When the United States eventually allows for the legalization of recreational cannabis, it will be set up for profits from both non-THC and THC products combined.

Meanwhile, shares could easily double in the next year at these prices. So, I would consider even a small stake in Canopy Growth stock to prepare for a bull market.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has positions in Canadian Imperial Bank Of Commerce, Canopy Growth, and NorthWest Healthcare Properties Real Estate Investment Trust. The Motley Fool recommends NorthWest Healthcare Properties Real Estate Investment Trust. The Motley Fool has a disclosure policy.

More on Investing

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Woman has an idea
Investing

3 No-Brainer Stocks to Buy With $200 Right Now

These three stocks are no-brainer buys, given their solid underlying businesses and healthy growth prospects.

Read more »

Investing

2 Stocks I’m Loading Up on in 2024

Alimentation Couche-Tard (TSX:ATD) and another stock that are getting too cheap after their latest corrections.

Read more »

grow money, wealth build
Dividend Stocks

1 Top Dividend Stock That Can Handle Any Kind of Market (Even Corrections)

While most dividend aristocrats can maintain their payouts during weak markets, very few can maintain a healthy valuation or bounce…

Read more »

Red siren flashing
Dividend Stocks

Income Alert: These Stocks Just Raised Their Dividends

Three established dividend-payers from different sectors are compelling investment opportunities for income-focused investors.

Read more »

online shopping
Tech Stocks

1 Hidden Catalyst That Could Ignite Shopify Stock

Here's why Shopify (TSX:SHOP) ought to remain a top growth stock investors continue to focus on for the long haul.

Read more »

Oil pumps against sunset
Energy Stocks

Is it Too Late to Buy Enbridge Stock?

Besides its juicy and sustainable dividends, Enbridge’s improving long-term growth prospects make it a reliable stock to hold for the…

Read more »

Man considering whether to sell or buy
Tech Stocks

WELL Stock: Buy, Sell, or Hold?

WELL stock has a lot of upside as the company is likely to continue to grow, posting positive earnings in…

Read more »